menu
    • menu

    Company profile for Personalis

    NEW Drugs in Dev: 3
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Personalis, Inc. is a provider of advanced genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. Our patented ACE (Accuracy and Content Enhanced) Technology forms the foundation of all Personalis products. ACE Technology improves every individual step in the next-generation sequencing (NGS) process, from nucleic acid extraction, ...
    Personalis, Inc. is a provider of advanced genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. Our patented ACE (Accuracy and Content Enhanced) Technology forms the foundation of all Personalis products. ACE Technology improves every individual step in the next-generation sequencing (NGS) process, from nucleic acid extraction, to sequencing assays, to data analytics. This makes it possible for us to achieve augmented coverage of difficult-to-sequence genomic regions that are missed with the use of conventional sequencing techniques.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PersonalisUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1330 O’Brien Drive Menlo Park, CA 94025
    Telephone
    Telephone
    +49 170 8121 888
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.personalis.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Personalis Expands Evidence For Ultrasensitive ctDNA Monitoring
    Personalis Expands Evidence For Ultrasensitive ctDNA Monitoring

    02 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260202837412/en/Personalis-Announces-New-Publication-Expanding-Evidence-for-Ultrasensitive-ctDNA-Monitoring-of-Cancer-Immunotherapy-Response-Across-Solid-Tumors

    BUSINESSWIRE
    02 Feb 2026
    Share Share
    Personalis Joins BTIG Medtech & Life Science Conference
    Personalis Joins BTIG Medtech & Life Science Conference

    28 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260128367499/en/Personalis-to-Participate-in-the-BTIG-13th-Annual-MedTech-Digital-Health-Life-Science-Diagnostic-Tools-Conference

    BUSINESSWIRE
    28 Jan 2026
    Share Share
    Personalis Launches Real-Time MRD Tracker
    Personalis Launches Real-Time MRD Tracker

    12 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260112393874/en/Personalis-Pioneers-Advancement-in-MRD-Testing-with-the-Launch-of-its-Real-Time-Variant-Tracker

    BUSINESSWIRE
    12 Jan 2026
    Share Share
    Personalis Reports Preliminary Q4 And Full Year 2025 Results
    Personalis Reports Preliminary Q4 And Full Year 2025 Results

    08 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260108479200/en/Personalis-Reports-Select-Preliminary-Fourth-Quarter-and-Full-Year-2025-Results-and-Recent-Highlights

    BUSINESSWIRE
    08 Jan 2026
    Share Share
    Personalis Publishes Study On Ultrasensitive Ctdna Testing
    Personalis Publishes Study On Ultrasensitive Ctdna Testing

    17 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251217599767/en/Personalis-Announces-New-Publication-Applying-Ultrasensitive-ctDNA-Testing-to-Monitoring-Cancer-Immunotherapy-Response-Across-Solid-Tumors

    BUSINESSWIRE
    17 Dec 2025
    Share Share
    New Study: NeXT Detection's Key Role in Lung Cancer
    New Study: NeXT Detection's Key Role in Lung Cancer

    11 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251211863347/en/New-Publication-Demonstrates-the-Importance-of-NeXT-Personal-Ultrasensitive-Detection-of-Residual-Disease-in-Lung-Cancer

    BUSINESSWIRE
    11 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search